BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 15788886)

  • 1. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
    Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications.
    Hiraoka A; Horiike N; Yamashita Y; Koizumi Y; Doi K; Yamamoto Y; Hasebe A; Ichikawa S; Yano M; Miyamoto Y; Ninomiya T; Otomi Y; Kokame M; Iwamura T; Ishimaru Y; Sogabe I; Kashihara K; Nishiura S; Ootani H; Takamura K; Kawasaki H
    Hepatogastroenterology; 2008; 55(88):2171-4. PubMed ID: 19260499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
    J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.
    Santambrogio R; Opocher E; Zuin M; Selmi C; Bertolini E; Costa M; Conti M; Montorsi M
    Ann Surg Oncol; 2009 Dec; 16(12):3289-98. PubMed ID: 19727960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.
    Eisele RM; Zhukowa J; Chopra S; Schmidt SC; Neumann U; Pratschke J; Schumacher G
    Eur J Surg Oncol; 2010 Mar; 36(3):269-74. PubMed ID: 19726155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection].
    Ren ZG; Gan YH; Fan J; Chen Y; Wu ZQ; Qin LX; Ge NL; Zhou J; Xia JL; Wang YH; Ye QH; Wang L; Ye SL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1614-6. PubMed ID: 19094752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
    Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Liu Z; Zhou Y; Zhang P; Qin H
    Surg Laparosc Endosc Percutan Tech; 2010 Jun; 20(3):130-40. PubMed ID: 20551807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with more than 500 minimally invasive hepatic procedures.
    Buell JF; Thomas MT; Rudich S; Marvin M; Nagubandi R; Ravindra KV; Brock G; McMasters KM
    Ann Surg; 2008 Sep; 248(3):475-86. PubMed ID: 18791368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
    Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
    J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
    Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
    Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.